What is the ROCE (Return on Capital Employed) of MorphoSys this year?
The ROCE of MorphoSys is -4.75 undefined this year.
MorphoSys ROCE 2024
MorphoSys ROCE
-4.75
Ticker
MOR.DE
ISIN
DE0006632003
WKN
663200
In 2024, MorphoSys's return on capital employed (ROCE) was -4.75, a 251.82% increase from the -1.35 ROCE in the previous year.
MorphoSys Aktienanalyse
What does MorphoSys do?
MorphoSys AG is a biotech company based in Planegg near Munich, Germany, founded in 1992. The company specializes in the discovery and development of therapeutic antibodies and operates worldwide. MorphoSys ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling MorphoSys's Return on Capital Employed (ROCE)
MorphoSys's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing MorphoSys's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
MorphoSys's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in MorphoSys’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about MorphoSys stock
How has the ROCE (Return on Capital Employed) of MorphoSys developed compared to the previous year?
The ROCE of MorphoSys has increased by 251.82% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of MorphoSys?
A high Return on Capital Employed (ROCE) indicates that MorphoSys has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of MorphoSys?
A low ROCE (Return on Capital Employed) can indicate that MorphoSys has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from MorphoSys impact the company?
An increase in the ROCE of MorphoSys can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of MorphoSys affect the company?
A decrease in ROCE of MorphoSys can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of MorphoSys?
Some factors that can affect MorphoSys's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of MorphoSys so important for investors?
The ROCE of MorphoSys is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can MorphoSys take to improve the ROCE?
To improve the ROCE, MorphoSys can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does MorphoSys pay?
Over the past 12 months, MorphoSys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MorphoSys is expected to pay a dividend of 0 EUR.
What is the dividend yield of MorphoSys?
The current dividend yield of MorphoSys is .
When does MorphoSys pay dividends?
MorphoSys pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MorphoSys?
MorphoSys paid dividends every year for the past 0 years.
What is the dividend of MorphoSys?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is MorphoSys located?
MorphoSys is assigned to the 'Health' sector.
Wann musste ich die Aktien von MorphoSys kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MorphoSys from 12/20/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.
When did MorphoSys pay the last dividend?
The last dividend was paid out on 12/20/2024.
What was the dividend of MorphoSys in the year 2023?
In the year 2023, MorphoSys distributed 0 EUR as dividends.
In which currency does MorphoSys pay out the dividend?
The dividends of MorphoSys are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The MorphoSys stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von MorphoSys
Our stock analysis for MorphoSys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MorphoSys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
